Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cephalon Expects To Reduce Modafinil Price For ADHD By About 40%

May 20 2005

• By Lee Kalowski

Related Content

Cephalon’s Nuvigil Filing Remains On Schedule For First Quarter

Feb 10 2005

Cephalon Will Add 250-Rep Pediatric Sales Force For Modafinil ADHD Launch

May 04 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window